ACCESSION: MSBNK-SMB_Measured-HSA031P0217005
RECORD_TITLE: Characterized; Threoninyl-Valine; LC-ESI-QTOF; MS2; NEGATIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.24, Processed 2025.02.24, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 10.000
COMMENT: MS2_M/Z_AVERAGED_THRES 15.000
COMMENT: DATASET_FILE_NUM 59
COMMENT: NUM_AVERAGED_SPEC 13
COMMENT: RAW_SPEC {'RA1-neg_1347': {'bp': 1271.0, 'sum': 3020.0}, 'RA1-neg_1296': {'bp': 858.0, 'sum': 1915.0}, 'RA1-neg_1311': {'bp': 827.0, 'sum': 2172.0}, 'RA10-neg_1422': {'bp': 526.0, 'sum': 1175.0}, 'HC12-neg_1508': {'bp': 523.0, 'sum': 1326.0}, 'HC12-neg_1521': {'bp': 474.0, 'sum': 932.0}, 'HC5-neg_1358': {'bp': 442.0, 'sum': 1003.0}, 'HC15-neg_1432': {'bp': 394.0, 'sum': 1056.0}, 'RA10-neg_1407': {'bp': 363.0, 'sum': 975.0}, 'HC26-neg_1398': {'bp': 358.0, 'sum': 1117.0}, 'RA20-neg_1418': {'bp': 301.0, 'sum': 964.0}, 'RA2-neg_1455': {'bp': 290.0, 'sum': 698.0}, 'RA23-neg_1356': {'bp': 283.0, 'sum': 818.0}}
COMMENT: RETENTION_TIME_STDEV 0.020
COMMENT: PRECURSOR_M/Z_RAW 217.120491
COMMENT: PRECURSOR_M/Z_STDEV 0.000442
COMMENT: PRECURSOR_IN_MS1 mz 217.119541; int 563.719; delta(ppm) -7.704857
COMMENT: PROPOSED_CHARGE_STATE -1; mz 218.122217; int 69.501; cor 0.890
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.885; C9H18N2O4; [M-H]1; delta(ppm) 0.884806
COMMENT: PROPOSED_MF MS-FINDER 4.226; C9H18N2O4; [M-H]-; delta(ppm) 0.890546
COMMENT: PROPOSED_MF MS-FINDER 2.395; C10H14N6; [M-H]-; delta(ppm) -5.269230
COMMENT: PROPOSED_MF SIRIUS5_Sirius 24.305; C9H18N2O4; [M-H]-; delta(ppm) 0.890546
COMMENT: PROPOSED_MF SIRIUS5_Sirius 5.628; C10H14N6; [M-H]-; delta(ppm) -5.269230
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C9H18N2O4; [M-H]-; delta(ppm) 0.890546
COMMENT: PROPOSED_MF SIRIUS6_Sirius 31.935; C9H18N2O4; [M-H]-; delta(ppm) 0.890546
COMMENT: PROPOSED_MF SIRIUS6_Sirius 19.598; C7H16N5O3; [M-H]-; delta(ppm) 7.074578
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.856; C10H14N6; [M-H]-; delta(ppm) -5.269230
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.680; C8H22N2OSi2; [M-H]-; delta(ppm) -227508.239106
COMMENT: PROPOSED_MF SIRIUS6_Sirius -5.110; C11H23PS; [M-H]-; delta(ppm) 4.807043
COMMENT: PROPOSED_MF SIRIUS6_Sirius -8.207; C6H17N7P; [M-H]-; delta(ppm) -6.692867
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C9H18N2O4; [M-H]-; delta(ppm) 0.890546
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.513; CKHWEVXPLJBEOZ-UHFFFAOYNA-N; [M-H]-; CC(C)C(NC(=O)C(N)C(C)O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.489; XGDCYUQSFDQISZ-UHFFFAOYNA-N; [M-H]-; CC(C)CC(N)C(=O)NC(CO)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.402; DJMJKPIOHKKBLO-UHFFFAOYSA-N; [M-H]-; OC1=CC2=C(C(O)=C1)C1(CC2)CCCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.386; JGGPAEFEKFAXSS-UMFDPSGLNA-N; [M-H]-; C[C@@H]1CC(=O)C(C(C)=O)=C2C=C(C)CC[C@@H]12
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.348; MDCPCLPRWLKUIQ-UHFFFAOYSA-N; [M-H]-; O=C(OC(C)(C)C)NC(C(=O)O)CCN
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.940; CKHWEVXPLJBEOZ-UHFFFAOYNA-N; [M-H]-; Threoninyl-Valine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.827; XGDCYUQSFDQISZ-UHFFFAOYNA-N; [M-H]-; Leucyl-Serine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.822; GVRKWABULJAONN-UHFFFAOYNA-N; [M-H]-; Valyl-Threonine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.786; BXLYSRPHVMCOPS-UHFFFAOYNA-N; [M-H]-; Serylisoleucine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.783; TVFTZQHBUQYHFH-MLWJPKLSSA-N; [M-H]-; (2S)-2-amino-6-(2-hydroxypropanoylamino)hexanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.759; RDSCWVPNCCOSMU-UHFFFAOYSA-N; [M-H]-; 1-[4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-3-(propan-2-yl)urea
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.727; LRUVDKTXDFISJO-UHFFFAOYSA-N; [M-H]-; CNP0437667
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.715; NFDYGNFETJVMSE-UHFFFAOYNA-N; [M-H]-; Serylleucine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.687; ZZYYVZYAZCMNPG-UHFFFAOYNA-N; [M-H]-; L-Lysopine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.649; WXTQYTUNJKJZQH-UHFFFAOYSA-N; [M-H]-; 4-hydroxy-5-oxo-2-[(trimethylamino)methyl]pyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.585; TWVKGYNQQAUNRN-UHFFFAOYNA-N; [M-H]-; Isoleucyl-Serine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.583; XCYPSOHOIAZISD-MLWJPKLSSA-N; [M-H]-; N(6)-(1-carboxyethyl)-L-lysine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.495; VUXMGAKZQBQIAH-UHFFFAOYSA-N; [M-H]-; N-(3-carboxypropanoyl)-N-hydroxycadaverine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.445; AMMYIDAXRNSZSJ-UHFFFAOYNA-N; [M-H]-; Pantothenamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.443; NPPQSCRMBWNHMW-UHFFFAOYSA-N; [M-H]-; Meprobamate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.427; SPBWCBIQZFYDOE-UHFFFAOYNA-N; [M-H]-; N(6)-(2-carboxyethyl)lysine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.418; BWWHOVJFNMPUKF-UHFFFAOYSA-N; [M-H]-; DIETHYL PROPANE-1,3-DIYLBISCARBAMATE
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.418; ALXLJPPLHFRKEJ-MLWJPKLSSA-N; [M-H]-; (2S)-2,6-diaminononanedioic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.321; UENLDOJJKXLRJI-ZETCQYMHSA-N; [M-H]-; (2S)-6-amino-2-(2-carboxyethylamino)hexanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.319; HZOQMZBZPWLKIO-IMTBSYHQSA-N; [M-H]-; (2R)-2-amino-2-[[(1S)-1-carboxyethyl]amino]-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.118; MDCPCLPRWLKUIQ-UHFFFAOYSA-N; [M-H]-; 4-amino-2-{[(tert-butoxy)carbonyl]amino}butanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.066; CZBYDJTWLGVCEV-UHFFFAOYSA-N; [M-H]-; 2,8-diaminononanedioic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.028; VSYMNDBTCKIDLT-UHFFFAOYSA-N; [M-H]-; [2-(carbamoyloxymethyl)-2-ethylbutyl] carbamate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.697; AKASJOQALJVEMD-UHFFFAOYSA-N; [M-H]-; 1,4,7-triazecane-1,4,7-tricarbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; TVFTZQHBUQYHFH-MLWJPKLSSA-N; [M-H]-; (2S)-2-amino-6-(2-hydroxypropanoylamino)hexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.959; BWWHOVJFNMPUKF-UHFFFAOYSA-N; [M-H]-; DIETHYL PROPANE-1,3-DIYLBISCARBAMATE
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.919; CKHWEVXPLJBEOZ-UHFFFAOYNA-N; [M-H]-; Threoninyl-Valine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.860; NPPQSCRMBWNHMW-UHFFFAOYSA-N; [M-H]-; Meprobamate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.860; VSYMNDBTCKIDLT-UHFFFAOYSA-N; [M-H]-; [2-(carbamoyloxymethyl)-2-ethylbutyl] carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.849; LRUVDKTXDFISJO-UHFFFAOYSA-N; [M-H]-; CNP0437667
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.802; RDSCWVPNCCOSMU-UHFFFAOYSA-N; [M-H]-; 1-[4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]-3-(propan-2-yl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.768; VUXMGAKZQBQIAH-UHFFFAOYSA-N; [M-H]-; N-(3-carboxypropanoyl)-N-hydroxycadaverine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.744; ZZYYVZYAZCMNPG-UHFFFAOYNA-N; [M-H]-; L-Lysopine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.744; UENLDOJJKXLRJI-ZETCQYMHSA-N; [M-H]-; (2S)-6-amino-2-(2-carboxyethylamino)hexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.693; MDCPCLPRWLKUIQ-UHFFFAOYSA-N; [M-H]-; 4-amino-2-{[(tert-butoxy)carbonyl]amino}butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.666; ALXLJPPLHFRKEJ-MLWJPKLSSA-N; [M-H]-; (2S)-2,6-diaminononanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.666; CZBYDJTWLGVCEV-UHFFFAOYSA-N; [M-H]-; 2,8-diaminononanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.665; SPBWCBIQZFYDOE-UHFFFAOYNA-N; [M-H]-; N(6)-(2-carboxyethyl)lysine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.665; XCYPSOHOIAZISD-MLWJPKLSSA-N; [M-H]-; N(6)-(1-carboxyethyl)-L-lysine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.651; AMMYIDAXRNSZSJ-UHFFFAOYNA-N; [M-H]-; Pantothenamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.611; TWVKGYNQQAUNRN-UHFFFAOYNA-N; [M-H]-; Isoleucyl-Serine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.611; XGDCYUQSFDQISZ-UHFFFAOYNA-N; [M-H]-; Leucyl-Serine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.599; GVRKWABULJAONN-UHFFFAOYNA-N; [M-H]-; Valyl-Threonine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.532; BXLYSRPHVMCOPS-UHFFFAOYNA-N; [M-H]-; Serylisoleucine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.532; NFDYGNFETJVMSE-UHFFFAOYNA-N; [M-H]-; Serylleucine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.528; HZOQMZBZPWLKIO-IMTBSYHQSA-N; [M-H]-; (2R)-2-amino-2-[[(1S)-1-carboxyethyl]amino]-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.308; NPPQSCRMBWNHMW-UHFFFAOYSA-N; [M-H]-; [2-(carbamoyloxymethyl)-2-methylpentyl] carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.997; CKHWEVXPLJBEOZ-VQVTYTSYSA-N; [M-H]-; (2S)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.907; NFDYGNFETJVMSE-BQBZGAKWSA-N; [M-H]-; (2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.125; MEFAXPOIMLNACU-UHFFFAOYSA-N; [M-H]-; 4-carbamoyloxyheptan-2-yl carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.051; VSYMNDBTCKIDLT-UHFFFAOYSA-N; [M-H]-; [2-(carbamoyloxymethyl)-2-ethylbutyl] carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.015; VUXMGAKZQBQIAH-UHFFFAOYSA-N; [M-H]-; 4-[5-aminopentyl(hydroxy)amino]-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.981; XYVDBMJJKIAKIK-UHFFFAOYSA-N; [M-H]-; 2-(carbamoyloxymethyl)hexyl carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.981; IHXNRXNBUPOFAS-UHFFFAOYSA-N; [M-H]-; [2-(carbamoyloxymethyl)-3-methylpentyl] carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.981; YXGDVAFWTHMZRW-UHFFFAOYSA-N; [M-H]-; 2-(1-carbamoyloxyethyl)pentyl carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.979; CYBHZZZXLCUSQA-UHFFFAOYSA-N; [M-H]-; [2-(carbamoyloxymethyl)-2,3-dimethylbutyl] carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.979; AZKKWGXMQLTBNB-UHFFFAOYSA-N; [M-H]-; [2-(carbamoyloxymethyl)-4-methylpentyl] carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.952; IPMKEQXUUSDMIW-UHFFFAOYSA-N; [M-H]-; [2-(carbamoyloxymethyl)-2-methylbutyl] N-methylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.937; BYCKHNZSBNGBQL-LURJTMIESA-N; [M-H]-; tert-butyl N-[(2S)-4-amino-1-hydroxy-4-oxobutan-2-yl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.904; MGZOLDRJCCCSOA-UHFFFAOYSA-N; [M-H]-; (3-carbamoyloxy-2,2-dimethylpropyl) N,N-dimethylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.904; TWWOBESSFAFJFD-UHFFFAOYSA-N; [M-H]-; 2-(carbamoyloxymethyl)butyl N,N-dimethylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.902; AMMYIDAXRNSZSJ-UHFFFAOYSA-N; [M-H]-; N-(3-amino-3-oxopropyl)-2,4-dihydroxy-3,3-dimethylbutanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.872; ZZYYVZYAZCMNPG-RQJHMYQMSA-N; [M-H]-; (2S)-6-amino-2-[[(1R)-1-carboxyethyl]amino]hexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.861; XJVZHKXGDQXSNT-UHFFFAOYSA-N; [M-H]-; tert-butyl N-[2-[methoxy(methyl)amino]-2-oxoethyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.858; XGDCYUQSFDQISZ-UHFFFAOYSA-N; [M-H]-; 2-[(2-amino-4-methylpentanoyl)amino]-3-hydroxypropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.858; TWVKGYNQQAUNRN-UHFFFAOYSA-N; [M-H]-; 2-[(2-amino-3-methylpentanoyl)amino]-3-hydroxypropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.846; GVRKWABULJAONN-BYRXKDITSA-N; [M-H]-; (2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-hydroxybutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.830; AXLHVTKGDPVANO-ZCFIWIBFSA-N; [M-H]-; methyl (2R)-2-amino-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.828; HNGRJOCEIWGCTB-LURJTMIESA-N; [M-H]-; methyl (2S)-3-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.818; MDCPCLPRWLKUIQ-LURJTMIESA-N; [M-H]-; (2S)-4-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.815; GHWNEGODOSNRLM-UHFFFAOYSA-N; [M-H]-; 2-(aminomethyl)-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.780; BXLYSRPHVMCOPS-ACZMJKKPSA-N; [M-H]-; (2S,3S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.679; JGMFEVONQBBJBM-UHFFFAOYSA-N; [M-H]-; [2-(carbamoyloxymethyl)-3,3-dimethylbutyl] carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.656; VGBDEALNUKLDKK-UHFFFAOYSA-N; [M-H]-; 1,3-bis(hydroxymethyl)-4-methoxy-5,5-dimethyl-1,3-diazinan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.601; LZQSLXNZORCPAR-UHFFFAOYSA-N; [M-H]-; 2-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethylamino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.578; VBJZDMOTYJEHEP-UHFFFAOYSA-N; [M-H]-; N,N'-dihydroxynonanediamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -5.492; CKHWEVXPLJBEOZ; [M-H]-; L-Valine, L-threonyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -41.612; GVRKWABULJAONN; [M-H]-; L-Threonine, L-valyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -162.614; BXLYSRPHVMCOPS; [M-H]-; L-Isoleucine, L-seryl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -168.514; TWVKGYNQQAUNRN; [M-H]-; isoleucylserine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -187.404; NFDYGNFETJVMSE; [M-H]-; serylleucine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.322; BWWHOVJFNMPUKF; [M-H]-; Diethyl Propane-1,3-Diylbiscarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -215.156; XGDCYUQSFDQISZ; [M-H]-; leucylserine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -250.682; CZBYDJTWLGVCEV; [M-H]-; 2,8-Diaminononanedioic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -281.281; MDCPCLPRWLKUIQ; [M-H]-; AmbotzBAA1087
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -282.040; QOALOSWUHLXFGM; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -294.393; CYBHZZZXLCUSQA; [M-H]-; 2-Isopropyl-2-methyl-1,3-propanediol dicarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -298.068; XCYPSOHOIAZISD; [M-H]-; Nz-(1-Carboxyethyl)-Lysine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -301.611; SPBWCBIQZFYDOE; [M-H]-; Epitope ID:150919
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -304.892; JGMFEVONQBBJBM; [M-H]-; 2-tert-Butyl-1,3-propanediol dicarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -307.480; AMMYIDAXRNSZSJ; [M-H]-; Pantothenamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -310.733; ZZYYVZYAZCMNPG; [M-H]-; Lysopine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -319.823; UENLDOJJKXLRJI; [M-H]-; (2S)-6-amino-2-(2-carboxyethylamino)hexanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -323.237; AZKKWGXMQLTBNB; [M-H]-; 2-Isobutyl-1,3-propanediol dicarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -326.912; VSYMNDBTCKIDLT; [M-H]-; Metuchen
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -331.860; HQHCPQNJWUYZEB; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -332.701; VIJSTDCSECADEX; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -341.761; IHXNRXNBUPOFAS; [M-H]-; 2-sec-Butyl-1,3-propanediol dicarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -342.093; PCXCXTZASITUBF; [M-H]-; Acetamide,N-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-piperidinyl]methyl]-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -343.944; IPMKEQXUUSDMIW; [M-H]-; 2-[(carbamoyloxy)methyl]-2-methylbutyl methylcarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -345.846; MGZOLDRJCCCSOA; [M-H]-; 3-(carbamoyloxy)-2,2-dimethylpropyl dimethylcarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -348.431; TWWOBESSFAFJFD; [M-H]-; 2-(carbamoyloxymethyl)butyl N,N-dimethylcarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -357.903; VBJZDMOTYJEHEP; [M-H]-; Azelaic bishydroxamic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -364.225; XYVDBMJJKIAKIK; [M-H]-; 2-Butyl-1,3-propanediol dicarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -368.943; RDSCWVPNCCOSMU; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -370.017; YXGDVAFWTHMZRW; [M-H]-; 2-Propyl-1,3-butanediol dicarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -372.111; NPPQSCRMBWNHMW; [M-H]-; Anatimon
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -383.722; XJVZHKXGDQXSNT; [M-H]-; N-BOC-glycine N -methoxy-N -methylamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -394.009; MEFAXPOIMLNACU; [M-H]-; heptane-2,4-diyl dicarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -412.046; VUXMGAKZQBQIAH; [M-H]-; N-hydroxy-N-succinylcadaverine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -426.048; VGBDEALNUKLDKK; [M-H]-; 1,3-bis(hydroxymethyl)-4-methoxy-5,5-dimethyl-1,3-diazinan-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -450.128; LTMXONUXADKEET; [M-H]-; (3aR,4R,5R,6R,6aS)-2-(dimethylamino)-6-(hydroxymethyl)-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[d][1,3]oxazole-4,5-diol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -455.697; LRUVDKTXDFISJO; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.405; CKHWEVXPLJBEOZ; [M-H]-; L-Valine, L-threonyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -6.081; CKHWEVXPLJBEOZ; [M-H]-; Thr-Val
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -62.409; GVRKWABULJAONN; [M-H]-; Val-Thr
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -249.222; MDCPCLPRWLKUIQ; [M-H]-; 4-amino-2-{[(tert-butoxy)carbonyl]amino}butanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -269.542; BXLYSRPHVMCOPS; [M-H]-; Ser-Ile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -274.826; BWWHOVJFNMPUKF; [M-H]-; Diethyl Propane-1,3-Diylbiscarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -292.345; TWVKGYNQQAUNRN; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -292.557; VIJSTDCSECADEX; [M-H]-; tert-butyl N-[(2S)-1-[formyl(hydroxy)amino]propan-2-yl]carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -320.128; NFDYGNFETJVMSE; [M-H]-; 2-(2-amino-3-hydroxypropanamido)-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -340.603; CYBHZZZXLCUSQA; [M-H]-; 1,3-Propanediol, 2-isopropyl-2-methyl-, dicarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -342.439; XJVZHKXGDQXSNT; [M-H]-; tert-Butyl (2-(methoxy(methyl)amino)-2-oxoethyl)carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.523; CKHWEVXPLJBEOZ; [M-H]-; Thr-Val
COMMENT: CONFIDENCE Level 3: Tentative candidate, Threoninyl-Valine, CKHWEVXPLJBEOZ-VQVTYTSYSA-N; Proposed by SIRIUS5_CSI with FDR < 0.05; Supported by other software with ranking <= 10 MetFrag:PubchemLite (2); This structural isomer was suggested from the biological context HMDB HMDB0029074;
CH$NAME: Threoninyl-Valine
CH$NAME: (2S)-2-[[(2S,3R)-2-azaniumyl-3-hydroxybutanoyl]amino]-3-methylbutanoate
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C9H18N2O4
CH$EXACT_MASS: 218.126657
CH$SMILES: C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)[O-])[NH3+])O
CH$IUPAC: InChI=1S/C9H18N2O4/c1-4(2)7(9(14)15)11-8(13)6(10)5(3)12/h4-7,12H,10H2,1-3H3,(H,11,13)(H,14,15)/t5-,6+,7+/m1/s1
CH$LINK: INCHIKEY CKHWEVXPLJBEOZ-VQVTYTSYSA-N
CH$LINK: PUBCHEM CID:7020901
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY -30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE -4.5 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 10.00; MS2(ppm) 15.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 µm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min, 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 2.042
MS$FOCUSED_ION: ION_TYPE [M-H]-
MS$FOCUSED_ION: PRECURSOR_M/Z 217.119574
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-014i-0900000000-77e3f0e882d10f1b4d86
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  73.0413363 173.7291 73.040979 17.0178 54.45 0.9389 11 f{C2H5N2O1}/8.21ppm,p-C7H12O3
  116.0722618 999.0000 116.071745 7.1249 0.00 0.8292 13 f{C5H10N1O2}/4.82ppm,p-C4H7N1O2
  116.9283440 209.0660 116.927831 11.2548 89.50 0.4746 12 ?
  124.8921655 131.5723 124.891687 13.2274 67.14 0.4384 10 ?
  129.1032234 390.4362 129.102767 9.0703 101.42 0.7399 13 f{C6H13N2O1}/-0.88ppm,p-C3H4O3
  173.0939170 179.2729 173.093839 11.0749 71.25 1.0000 13 f{C7H13N2O3}/4.34ppm,p-C2H4O1
  199.8513745 218.1250 199.850354 13.6201 102.47 0.3980 13 ?
PK$NUM_PEAK: 7
PK$PEAK: m/z int. rel.int.
  73.041336 173.73 173
  116.072262 999.00 999
  116.928344 209.07 209
  124.892165 131.57 131
  129.103223 390.44 390
  173.093917 179.27 179
  199.851374 218.12 218
//
